85 related articles for article (PubMed ID: 21070862)
21. Paracoccidioidomycosis and its etiologic agent Paracoccidioides brasiliensis.
San-Blas G
J Med Vet Mycol; 1993; 31(2):99-113. PubMed ID: 8509955
[TBL] [Abstract][Full Text] [Related]
22.
Zonta YR; Dezen ALO; Della Coletta AM; Yu KST; Carvalho L; Dos Santos LA; Deprá IC; Kratofil RM; Willson ME; Zbytnuik L; Kubes P; Ximenes VF; Dias-Melicio LA
Front Cell Infect Microbiol; 2020; 10():592022. PubMed ID: 33643928
[TBL] [Abstract][Full Text] [Related]
23. Experimental paracoccidioidomycosis: early immunosuppression occurs in susceptible mice after infection with pathogenic fungi.
Teixeira HC; Calich VL; Singer-Vermes LM; D'Imperio-Lima MR; Russo M
Braz J Med Biol Res; 1987; 20(5):587-9. PubMed ID: 3452450
[TBL] [Abstract][Full Text] [Related]
24. Identification of a metallopeptidase with TOP-like activity in Paracoccidioides brasiliensis, with increased expression in a virulent strain.
Gravi ET; Paschoalin T; Dias BR; Moreira DF; Belizario JE; Oliveira V; Carmona AK; Juliano MA; Travassos LR; Rodrigues EG
Med Mycol; 2012 Jan; 50(1):81-90. PubMed ID: 21728754
[TBL] [Abstract][Full Text] [Related]
25. Effects of cytochalasin E on Paracoccidioides brasiliensis.
Mendes G; Baltazar LM; Souza DG; Sá NP; Rosa LH; Rosa CA; Souza-Fagundes EM; Ramos JP; Alves-Silva J; Cota BB; Johann S
J Appl Microbiol; 2018 Nov; 125(5):1296-1307. PubMed ID: 30053334
[TBL] [Abstract][Full Text] [Related]
26. Experimental chemotherapy in paracoccidioidomycosis using ruthenium NO donor.
Pavanelli WR; da Silva JJ; Panis C; Cunha TM; Costa IC; de Menezes MC; Oliveira FJ; Lopes LG; Cecchini R; Cunha Fde Q; Watanabe MA; Itano EN
Mycopathologia; 2011 Aug; 172(2):95-107. PubMed ID: 21437728
[TBL] [Abstract][Full Text] [Related]
27. Thiosemicarbazone of lapachol acts on cell membrane in Paracoccidioides brasiliensis.
de Sá NP; Cisalpino PS; Bertollo CM; Santos PC; Rosa CA; de Souza DDG; Barbeira PJS; Alves TMA; Zani CL; Johann S
Med Mycol; 2019 Apr; 57(3):332-339. PubMed ID: 29945180
[TBL] [Abstract][Full Text] [Related]
28. Adherence and intracellular parasitism of Paracoccidioides brasiliensis in Vero cells.
Hanna SA; Monteiro da Silva JL; Giannini MJ
Microbes Infect; 2000 Jul; 2(8):877-84. PubMed ID: 10962270
[TBL] [Abstract][Full Text] [Related]
29. Virulence profile of ten Paracoccidioides brasiliensis isolates: association with morphologic and genetic patterns.
Kurokawa CS; Lopes CR; Sugizaki MF; Kuramae EE; Franco MF; Peraçoli MT
Rev Inst Med Trop Sao Paulo; 2005; 47(5):257-62. PubMed ID: 16302108
[TBL] [Abstract][Full Text] [Related]
30. Plasma amylase levels as a marker of disease severity in an isogenic murine model of paracoccidioidomycosis.
Xidieh CF; Singer-Vermes LM; Calich VL; Burger E
J Med Vet Mycol; 1994; 32(1):37-45. PubMed ID: 7515958
[TBL] [Abstract][Full Text] [Related]
31. Peptides Derived from a Phage Display Library Inhibit Adhesion and Protect the Host against Infection by
de Oliveira HC; Michaloski JS; da Silva JF; Scorzoni L; de Paula E Silva AC; Marcos CM; Assato PA; Yamazaki DS; Fusco-Almeida AM; Giordano RJ; Mendes-Giannini MJ
Front Pharmacol; 2016; 7():509. PubMed ID: 28066254
[No Abstract] [Full Text] [Related]
32. Antifungal activity of extracts from Atacama Desert fungi against Paracoccidioides brasiliensis and identification of Aspergillus felis as a promising source of natural bioactive compounds.
Mendes G; Gonçalves VN; Souza-Fagundes EM; Kohlhoff M; Rosa CA; Zani CL; Cota BB; Rosa LH; Johann S
Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):209-17. PubMed ID: 27008375
[TBL] [Abstract][Full Text] [Related]
33. Targeting the Homoserine Dehydrogenase of Paracoccidioides Species for Treatment of Systemic Fungal Infections.
Bagatin MC; Pimentel AL; Biavatti DC; Basso EA; Kioshima ES; Seixas FAV; Gauze GF
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652239
[TBL] [Abstract][Full Text] [Related]
34. Radiochemical pharmacokinetic profile of P10 peptide with antifungal properties.
Faintuch BL; Oliveira EA; Munõz JE; Travassos LR; Taborda CP
Med Mycol; 2014 Jul; 52(5):546-51. PubMed ID: 24934802
[TBL] [Abstract][Full Text] [Related]
35. Antifungal activity of two oxadiazole compounds for the paracoccidioidomycosis treatment.
Rodrigues-Vendramini FAV; Faria DR; Arita GS; Capoci IRG; Sakita KM; Caparroz-Assef SM; Becker TCA; de Souza Bonfim-Mendonça P; Felipe MS; Svidzinski TIE; Maigret B; Kioshima ÉS
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007441. PubMed ID: 31163021
[TBL] [Abstract][Full Text] [Related]
36. Transcriptome Profile of the Response of Paracoccidioides spp. to a Camphene Thiosemicarbazide Derivative.
do Carmo Silva L; Tamayo Ossa DP; Castro SV; Bringel Pires L; Alves de Oliveira CM; Conceição da Silva C; Coelho NP; Bailão AM; Parente-Rocha JA; Soares CM; Ruiz OH; Ochoa JG; Pereira M
PLoS One; 2015; 10(6):e0130703. PubMed ID: 26114868
[TBL] [Abstract][Full Text] [Related]
37. Gelatinase activity of exoantigens from virulent and non-virulent isolates of Paracoccidioides brasiliensis.
Vaz CA; Mackenzie DW; Hearn V; Camargo ZP; Singer-Vermes LM; Burger E; Calich VL
J Med Vet Mycol; 1994; 32(1):65-9. PubMed ID: 8207624
[TBL] [Abstract][Full Text] [Related]
38. Virulence of a variant of Paracoccidioides brasiliensis that exists in the yeast form at room temperature.
Villar LA; Restrepo A
J Med Vet Mycol; 1989; 27(3):141-8. PubMed ID: 2778575
[TBL] [Abstract][Full Text] [Related]
39. Chloroquine inhibits Paracoccidioides brasiliensis survival within human monocytes by limiting the availability of intracellular iron.
Dias-Melicio LA; Moreira AP; Calvi SA; Soares AM
Microbiol Immunol; 2006; 50(4):307-14. PubMed ID: 16625052
[TBL] [Abstract][Full Text] [Related]
40. Alterations in the pathogenicity of one Paracoccidioides brasiliensis isolate do not correlative with its in vitro growth.
Kashino SS; Singer-Vermes LM; Calich VL; Burger E
Mycopathologia; 1990 Sep; 111(3):173-80. PubMed ID: 2233986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
